New strategy for COVID-19 vaccination: targeting the receptor

Protein-based vaccines against SARS-CoV-2 may provide advantages

News & Comment Cellular & Molecular Immunology

Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine

Difficult transmembrane protein targets for therapeutic antibodies

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach

Cancers, Free Full-Text

The Race to Future-Proof Coronavirus Vaccines

In search of a pan-coronavirus vaccine: next-generation vaccine

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

PDF) Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

Viral targets for vaccines against COVID-19